Gritstone Bio (NASDAQ:GRTS) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.37) by 8.11 percent. This is a 440 percent decrease over earnings of $0.10 per share from the
BeyondSpring (the “Company” or “BeyondSpring”) (NASDAQ:BYSI), a global pharmaceutical company focused on the development of cancer therapeutics, today announced three poster presentations of new
Turquoise Hill Resources (NYSE:TRQ) reported quarterly earnings of $0.41 per share which beat the analyst consensus estimate of $0.36 by 13.89 percent. This is a 14.58 percent decrease over earnings of $0.48 per share